Market Overview

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

612.81 +34.60 (5.98%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/27/20CFRAMaintainsHold549.0
5/27/20SVB LeerinkReiteratesOutperform625.0
5/26/20Wells FargoUpgradesOverweight734.0
5/06/20BairdMaintainsNeutral510.0
5/06/20BMO CapitalMaintainsMarket Perform525.0
5/06/20Morgan StanleyMaintainsEqual-Weight555.0
5/06/20Credit SuisseMaintainsOutperform605.0
5/06/20SVB LeerinkMaintainsOutperform622.0
4/28/20Canaccord GenuityMaintainsBuy575.0
4/28/20CitigroupDowngradesNeutral575.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter